UBS Group’s Benessere Capital Acquisition Corp. Class A Common Stock BENE Stock Holding History

UBS Group’s Portfolio BENE Stock Details BENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,566	Closed	-$58K	–	11881
2022 Q3	$58K	Sell	5,566 -7,687	-58%	-$79.7K	﹤0.01%	6206
2022 Q2	$137K	Buy	13,253 +11,306	+581%	+$116K	﹤0.01%	5194
2022 Q1	$20K	Sell	1,947 -9,030	-82%	-$92.2K	﹤0.01%	7492
2021 Q4	$111K	Buy	10,977 +9,732	+782%	+$101K	﹤0.01%	6229
2021 Q3	$13K	Buy	1,245 +900	+261%	+$9.02K	﹤0.01%	7716
2021 Q2	$3K	Buy	345 +36	+12%	+$360	﹤0.01%	8888
2021 Q1	$3K	Buy	+309	New	+$3.11K	﹤0.01%	8563

UBS Group's BENE Position: Q4 2022 in Review

UBS Group sold out of Benessere Capital Acquisition Corp. Class A Common Stock (BENE) in Q4 2022, closing a stake of 5,566 shares — an estimated $58K sold.

UBS Group first reported a position in BENE in Q1 2021 and held it in 7 quarters. The position peaked at $137K in Q2 2022. 0 funds tracked by Wall St. Rank hold BENE as of Q4 2022.

UBS Group reported no remaining Benessere Capital Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 5,566 Benessere Capital Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $58K.
UBS Group first reported a position in Benessere Capital Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
UBS Group's Benessere Capital Acquisition Corp. Class A Common Stock position peaked at $137K in Q2 2022.
0 funds tracked by Wall St. Rank held Benessere Capital Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.